Epigenetics Research

Over the past two decades it has become evident that there is another layer of information that sits “above” DNA-encoded genetic information in humans and other complex organisms. This information, termed “epi”genetic information, is embedded in the chemical modification of DNA and the histone proteins around which it is wrapped.

Epigenetic information determines the structure of DNA, that is how DNA is organised in the cell, which in turn determines which genes or noncoding RNAs are expressed and control normal development. Unlike genomic information epigenetic changes are also potentially influenced by environmental factors, especially during early development and can then be somatically inherited between cell generations leading to increased disease susceptibility.

The importance of epigenetics in normal development and in many disease states, including cancer, is well established but understanding the biology of DNA methylation and chromatin remodelling and the role of noncoding RNA in gene control is still in its infancy. The Clark Lab has the capability and developed high throughput sequencing tools required “to unravel the epigenome” and are now developing more sophisticated bioinformatics and capability to build and interpret reference epigenome maps of normal and diseased cells to both understand epigenome biology and address how this impacts on disease states.

The main aims of the Clark Epigenetics Research Laboratory are 1) Basic Research to elucidate how the pattern of spatial and temporal epigenetic processes control normal cell control, and how disruption of these processes contributes primarily to prostate and breast cancer and other diseases, including diabetes and obesity; 2) Translational research to mediate the translation of this knowledge into the clinical setting to improve health outcomes, through development of epigenetic-based biomarkers and potential therapeutic targets; and 3) Training to foster opportunities for talented laboratory and bioinformatic researchers to build their careers in epigenomic research in Australia.

Epigenetics and Cancer

Watch Professor Susan Clark discuss her journey into studying epigenetics and methylation in cancer in a recent interview at the 81st Cold Spring Harbor Laboratory Symposium on Quantitative Biology: Targeting Cancer.


The Clark Lab is multicultural, with researchers from all over the world working together to combine their epigenetics expertise.

  Home countries of Epigenetics lab members


Watch our videos to learn more about our epigenetics research:

What is Epigenetics?

DNA Methylation and Cancer and DNA Methylation Biomarkers are two new releases in a series of sketch videos about epigenetics, created by Armando Hasudungan in collaboration with Professor Susan Clark and Dr Kate Patterson here at the Garvan Institute.


 Watch more of our epigenetics videos in our VIDEOS & LINKS tab above.

In the News

‘Forgotten molecule’ takes centre stage in cancer gene silencing - Sep 08, 2016
Epigenetics enters the arena of personalised medicine - Jul 01, 2016
A 3D view of the cancer genome - Jun 06, 2016
2016 recipients of the Heliflite Young Explorer and CHAMP Young Pioneer Awards and the Palmer Innovation Prize announced - May 05, 2016
Schizophrenia and DNA methylation in the developing brain - Dec 09, 2015
Nadine Watson lecture takes place at Garvan - Dec 07, 2015
Student success at EMBL Australia Symposium - Dec 01, 2015
NHMRC funding success for Garvan researchers - Nov 09, 2015
Professor Susan Clark receives Make a Difference Award for outstanding cancer research - Aug 10, 2015
How some breast cancers become resistant to hormone therapy - Jul 15, 2015
Professor Susan Clark elected Fellow of the Australian Academy of Science - May 25, 2015
Students Receive Awards at 2015 Lorne Genome Conference - Feb 25, 2015
Saul Bert Awarded 2014 Garvan Thesis Prize - Feb 19, 2015
Epigenetic signatures that differentiate triple-negative breast cancers - Feb 02, 2015
Garvan receives $15.5 million in NHMRC funding round - Oct 25, 2013
New hope for hormone resistant breast cancer - Jul 23, 2013
Cancer study overturns current thinking about gene activation - Dec 14, 2012
Enhancing prostate cancer prognosis at the micro level - Aug 07, 2012
Four organisations use epigenetics to beat obesity - Jul 25, 2012
Rotary awards Garvan epigeneticist in 2012 - Mar 28, 2012
Potential for earlier diagnosis of ovarian cancer - Jan 24, 2012
There is no such thing as identical where twins are concerned - Oct 12, 2011
Seminal shift in how we view cancer development - Jul 26, 2011
How we can better ‘mine’ our genome for information - Nov 04, 2010
What it might take to unravel the ‘lean mean machine’ that is cancer - Feb 22, 2010
Epigenetics featured in NHMRC ‘Ten of the Best Research Projects 2009’ - Aug 18, 2009
A step towards finding the cancer switch - Jun 17, 2009
New Australian Epigenome Alliance moves towards a Brave New World - Aug 23, 2008
Garvan cancer researcher wins Premier's Award - Jun 19, 2008
Cancer genetics to combine forces with nanotechnology to fight breast cancer - Oct 05, 2007

Loading jobs...